These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19060856)

  • 21. Erythropoietin and erythropoietin receptor.
    Tilbrook PA; Klinken SP
    Growth Factors; 1999; 17(1):25-35. PubMed ID: 10495960
    [No Abstract]   [Full Text] [Related]  

  • 22. [Similarity of biotechnology-derived drugs: regulatory framework and specificity].
    Prugnaud JL
    Ann Pharm Fr; 2008 Aug; 66(4):206-11. PubMed ID: 18847566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressuring insurers to pay for medically unnecessary treatments.
    Chapin G
    Manag Care Interface; 2003 Dec; 16(12):19-20. PubMed ID: 14750458
    [No Abstract]   [Full Text] [Related]  

  • 24. The cellular biology of erythropoietin receptors.
    Lappin T
    Oncologist; 2003; 8 Suppl 1():15-8. PubMed ID: 12626783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Indian effort towards affordable drugs: "generic to designer drugs".
    Taneja B; Yadav J; Chakraborty TK; Brahmachari SK
    Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440
    [No Abstract]   [Full Text] [Related]  

  • 26. Genzyme resumes shipping as Sanofi-aventis hovers.
    Ratner M
    Nat Biotechnol; 2010 Oct; 28(10):994. PubMed ID: 20944572
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone mimicry.
    Wells JA
    Science; 1996 Jul; 273(5274):449-50. PubMed ID: 8677438
    [No Abstract]   [Full Text] [Related]  

  • 28. An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.
    Jeong JY; Hoxhaj G; Socha AL; Sytkowski AJ; Feldman L
    Mol Cancer Res; 2009 Jul; 7(7):1150-7. PubMed ID: 19567780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin and its lost receptor.
    Sturiale A; Campo S; Crascì E; Coppolino G; Bolignano D; Grasso G; Buemi M
    Nephrol Dial Transplant; 2007 May; 22(5):1484-5. PubMed ID: 17267537
    [No Abstract]   [Full Text] [Related]  

  • 30. [Erythropoietin].
    Jin XC
    Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):73-6. PubMed ID: 7604230
    [No Abstract]   [Full Text] [Related]  

  • 31. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copycat consolidation.
    Wadman M
    Nature; 2007 Sep; 449(7161):393. PubMed ID: 17898741
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 34. Will any dimer do?
    Ballinger MD; Wells JA
    Nat Struct Biol; 1998 Nov; 5(11):938-40. PubMed ID: 9808034
    [No Abstract]   [Full Text] [Related]  

  • 35. New LSD therapies unfolding.
    Kozarich JW
    Chem Biol; 2007 Sep; 14(9):976-7. PubMed ID: 17884629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 37. Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises.
    Gorlin DI
    Food Drug Law J; 2008; 63(4):823-64. PubMed ID: 19601385
    [No Abstract]   [Full Text] [Related]  

  • 38. White paper. The five myths of generic competition. A Pharma Matters report. March 2009.
    Drug News Perspect; 2009 Apr; 22(3):171-5. PubMed ID: 19440560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Market watch: Sales of biologics to show robust growth through to 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.